Progressive Aggregation of Alpha-Synuclein and Selective Degeneration of Lewy Inclusion-Bearing Neurons in a Mouse Model of Parkinsonism

Cell Reports

Volumn 10, Issue 8, 2015, Pages 1252-1260

  Osterberg, ValerieR ^a   Spinelli, KateriJ ^a   Weston, LeahJ ^a   Luk, KelvinC ^b   Woltjer, RandallL ^c   Unni, VivekK ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; GREEN FLUORESCENT PROTEIN; RECOMBINANT PROTEIN; SERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CELL FATE; CELL FREE SYSTEM; CELL INCLUSION; CELL MATURATION; CONTROLLED STUDY; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FRONTAL CORTEX; HUMAN; IN VIVO STUDY; INTRACELLULAR SPACE; LEWY BODY; MOUSE; MULTIPHOTON MICROSCOPY; NERVE CELL; NEUROFILAMENT; NONHUMAN; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PROCESSING; SOMATIC CELL; AGED; ANIMAL; DISEASE MODEL; FEMALE; FRONTAL LOBE; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PARKINSON DISEASE; PATHOLOGY;

AGED; ALPHA-SYNUCLEIN; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FRONTAL LOBE; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; MALE; MICE; NEURONS; PARKINSON DISEASE;

EID: 84924554924     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.01.060     Document Type: Article

References (34)

1. Bodner R.A., Outeiro T.F., Altmann S., Maxwell M.M., Cho S.H., Hyman B.T., McLean P.J., Young A.B., Housman D.E., Kazantsev A.G. Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases. Proc. Natl. Acad. Sci. USA 2006, 103:4246-4251.
2. Brundin P., Li J.Y., Holton J.L., Lindvall O., Revesz T. Research in motion: the enigma of Parkinson's disease pathology spread. Nat. Rev. Neurosci. 2008, 9:741-745.
3. Dale G.E., Probst A., Luthert P., Martin J., Anderton B.H., Leigh P.N. Relationships between Lewy bodies and pale bodies in Parkinson's disease. Acta Neuropathol. 1992, 83:525-529.
4. Desplats P., Spencer B., Coffee E., Patel P., Michael S., Patrick C., Adame A., Rockenstein E., Masliah E. Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. J.Biol. Chem. 2011, 286:9031-9037.
5. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114:2283-2301.
6. Fraser P.E. Prions and prion-like proteins. J.Biol. Chem. 2014, 289:19839-19840.
7. Gertz H.J., Siegers A., Kuchinke J. Stability of cell size and nucleolar size in Lewy body containing neurons of substantia nigra in Parkinson's disease. Brain Res. 1994, 637:339-341.
8. Golde T.E., Borchelt D.R., Giasson B.I., Lewis J. Thinking laterally about neurodegenerative proteinopathies. J.Clin. Invest. 2013, 123:1847-1855.
9. Gómez-Tortosa E., Newell K., Irizarry M.C., Sanders J.L., Hyman B.T. alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathol. 2000, 99:352-357.
10. Greffard S., Verny M., Bonnet A.M., Seilhean D., Hauw J.J., Duyckaerts C. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol. Aging 2010, 31:99-103.
11. Guo J.L., Lee V.M. Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat. Med. 2014, 20:130-138.
12. Jucker M., Walker L.C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 2013, 501:45-51.
13. Kuchibhotla K.V., Goldman S.T., Lattarulo C.R., Wu H.Y., Hyman B.T., Bacskai B.J. Abeta plaques lead to aberrant regulation of calcium homeostasis invivo resulting in structural and functional disruption of neuronal networks. Neuron 2008, 59:214-225.
14. Leverenz J.B., Hamilton R., Tsuang D.W., Schantz A., Vavrek D., Larson E.B., Kukull W.A., Lopez O., Galasko D., Masliah E., et al. Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol. 2008, 18:220-224.
15. Liu X., Lee Y.J., Liou L.C., Ren Q., Zhang Z., Wang S., Witt S.N. Alpha-synuclein functions in the nucleus to protect against hydroxyurea-induced replication stress in yeast. Hum. Mol. Genet. 2011, 20:3401-3414.
16. Lu L., Neff F., Alvarez-Fischer D., Henze C., Xie Y., Oertel W.H., Schlegel J., Hartmann A. Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease. Exp. Neurol. 2005, 195:27-39.
17. Luk K.C., Kehm V.M., Zhang B., O'Brien P., Trojanowski J.Q., Lee V.M. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J.Exp. Med. 2012, 209:975-986.
18. Luk K.C., Kehm V., Carroll J., Zhang B., O'Brien P., Trojanowski J.Q., Lee V.M. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012, 338:949-953.
19. Ma K.L., Song L.K., Yuan Y.H., Zhang Y., Yang J.L., Zhu P., Chen N.H. α-Synuclein is prone to interaction with the GC-box-like sequence invitro. Cell. Mol. Neurobiol. 2014, 34:603-609.
20. Maroteaux L., Campanelli J.T., Scheller R.H. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J.Neurosci. 1988, 8:2804-2815.
21. Masuda-Suzukake M., Nonaka T., Hosokawa M., Oikawa T., Arai T., Akiyama H., Mann D.M., Hasegawa M. Prion-like spreading of pathological α-synuclein in brain. Brain 2013, 136:1128-1138.
22. Parkkinen L., O'Sullivan S.S., Collins C., Petrie A., Holton J.L., Revesz T., Lees A.J. Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease. J Parkinsons Dis 2011, 1:277-286.
23. Rockenstein E., Schwach G., Ingolic E., Adame A., Crews L., Mante M., Pfragner R., Schreiner E., Windisch M., Masliah E. Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein. J.Neurosci. Res. 2005, 80:247-259.
24. Sacino A.N., Brooks M., Thomas M.A., McKinney A.B., McGarvey N.H., Rutherford N.J., Ceballos-Diaz C., Robertson J., Golde T.E., Giasson B.I. Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice. Acta Neuropathol. 2014, 127:645-665.
25. Sacino A.N., Brooks M., Thomas M.A., McKinney A.B., Lee S., Regenhardt R.W., McGarvey N.H., Ayers J.I., Notterpek L., Borchelt D.R., et al. Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc. Natl. Acad. Sci. USA 2014, 111:10732-10737.
26. Sacino A.N., Brooks M., McKinney A.B., Thomas M.A., Shaw G., Golde T.E., Giasson B.I. Brain injection of α-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker. J.Neurosci. 2014, 34:12368-12378.
27. Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., Preibisch S., Rueden C., Saalfeld S., Schmid B., et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 2012, 9:676-682.
28. Spinelli K.J., Taylor J.K., Osterberg V.R., Churchill M.J., Pollock E., Moore C., Meshul C.K., Unni V.K. Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease. J.Neurosci. 2014, 34:2037-2050.
29. Styren S.D., Hamilton R.L., Styren G.C., Klunk W.E. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. J.Histochem. Cytochem. 2000, 48:1223-1232.
30. Tanaka M., Kim Y.M., Lee G., Junn E., Iwatsubo T., Mouradian M.M. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J.Biol. Chem. 2004, 279:4625-4631.
31. Unni V.K., Weissman T.A., Rockenstein E., Masliah E., McLean P.J., Hyman B.T. Invivo imaging of alpha-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobility. PLoS ONE 2010, 5:e10589.
32. Volpicelli-Daley L.A., Luk K.C., Patel T.P., Tanik S.A., Riddle D.M., Stieber A., Meaney D.F., Trojanowski J.Q., Lee V.M. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011, 72:57-71.
33. Wakabayashi K., Tanji K., Odagiri S., Miki Y., Mori F., Takahashi H. The Lewy body in Parkinson's disease and related neurodegenerative disorders. Mol. Neurobiol. 2013, 47:495-508.
34. Waxman E.A., Giasson B.I. Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein. J.Neuropathol. Exp. Neurol. 2008, 67:402-416.